Concepedia

Lalita Noronha‐Blob

LN

37

Publications

1.2K

Citations

22

H-Index

1976

Active since

Affiliations

Nova Medical (United States)(Current)

National Institutes of Health

Freeport-McMoRan (United States)

National Institute on Aging

Nova Research Company (United States)

Lalita Noronha‐Blob is an author at Nova Medical (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1976–1994

37

Publications

37

Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border.

Dontscho Kerjaschki, Lalita Noronha‐Blob, Bertram Sacktor et al. · The Journal of Cell Biology · 1984 · 176 citations · Full text

, , +25

Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs.

Lalita Noronha‐Blob, James F. Kachur · Journal of Pharmacology and Experimental Therapeutics · 1990 · 87 citations

Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder.

Lalita Noronha‐Blob, Valerie C. Lowe, Amanda J. Patton et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 75 citations

R and S enantiomers of oxybutynin: pharmacological effects in guinea pig bladder and intestine.

James F. Kachur, Jan S. Peterson, J P Carter et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 64 citations

Mice treated with a leumedin or antibody to Mac-1 to inhibit leukocyte sequestration survive endotoxin challenge

Ronald M. Burch, Lalita Noronha‐Blob, Jenny M. Bator et al. · The Journal of Immunology · 1993 · 47 citations

Rows per page

1–5 of 37